Erratum to: High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia (npj Biofilms and Microbiomes, (2017), 3, 1, (34), 10.1038/s41522-017-0040-3);High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia

npj Biofilms and Microbiomes

Volumn 3, Issue 1, 2017, Pages

  Drewes, Julia L ^a   White, James R ^b   Dejea, Christine M ^a   Fathi, Payam ^a   Iyadorai, Thevambiga ^c   Vadivelu, Jamuna ^c   Roslani, April C ^c   Wick, Elizabeth C ^a   Mongodin, Emmanuel F ^d   Loke, Mun Fai ^c   Thulasi, Kumar ^c   Gan, Han Ming ^e   Goh, Khean Lee ^c   Chong, Hoong Yin ^c   Kumar, Sandip ^c   Wanyiri, Jane W ^a   Sears, Cynthia L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Resphera Biosciences   (United States)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85042190738     PISSN: None     EISSN: 20555008     Source Type: Journal    
DOI: 10.1038/s41522-018-0078-x     Document Type: Erratum

References (72)

1. Boyle, P. & Langman, J. S. ABC of colorectal cancer: Epidemiology. BMJ 321, 805-808 (2000).
2. Burns, M. B., Lynch, J., Starr, T. K., Knights, D. & Blekhman, R. Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment. Genome Med. 7, 55 (2015).
3. Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292-298 (2012).
4. Sobhani, I. et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 6, e16393 (2011).
5. Baxter, N. T., Ruffin, M. T. T., Rogers, M. A. & Schloss, P. D. Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Med. 8, 37 (2016).
6. Geng, J., Fan, H., Tang, X., Zhai, H. & Zhang, Z. Diversified pattern of the human colorectal cancer microbiome. Gut Pathog. 5, 2 (2013).
7. Geng, J. et al. Co-occurrence of driver and passenger bacteria in human colorectal cancer. Gut Pathog. 6, 26 (2014).
8. Zhang, Z. et al. Spatial heterogeneity and co-occurrence patterns of human mucosal-associated intestinal microbiota. ISME J. 8, 881-893 (2014).
9. Zackular, J. P., Rogers, M. A., Ruffin, M. T. T. & Schloss, P. D. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev. Res. (Phila.) 7, 1112-1121 (2014).
10. Gao, Z., Guo, B., Gao, R., Zhu, Q. & Qin, H. Microbiota disbiosis is associated with colorectal cancer. Front. Microbiol. 6, 20 (2015).
11. Wang, T. et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 6, 320-329 (2012).
12. Weir, T. L. et al. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 8, e70803 (2013).
13. Marchesi, J. R. et al. Towards the human colorectal cancer microbiome. PLoS One 6, e20447 (2011).
14. Mira-Pascual, L. et al. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J. Gastroenterol. 50, 167-179 (2015).
15. Nakatsu, G. et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat. Commun. 6, 8727 (2015).
16. Dejea, C. M. et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc. Natl. Acad. Sci. USA 111, 18321-18326 (2014).
17. Eckburg, P. B. et al. Diversity of the human intestinal microbial flora. Science 308, 1635-1638 (2005).
18. Costerton, J. W., Stewart, P. S. & Greenberg, E. P. Bacterial biofilms: A common cause of persistent infections. Science 284, 1318-1322 (1999).
19. Bjarnsholt, T. et al. The in vivo biofilm. Trends Microbiol. 21, 466-474 (2013).
20. Worlitzsch, D. et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109, 317-325 (2002).
21. Derrien, M. et al. Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 1, 254-268 (2010).
22. Palestrant, D. et al. Microbial biofilms in the gut: Visualization by electron microscopy and by acridine orange staining. Ultrastruct. Pathol. 28, 23-27 (2004).
23. Swidsinski, A., Weber, J., Loening-Baucke, V., Hale, L. P. & Lochs, H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J. Clin. Microbiol. 43, 3380-3389 (2005).
24. Daquigan, N., Grim, C. J., White, J. R., Hanes, D. E. & Jarvis, K. G. Early recovery of salmonella from food using a 6-hour non-selective pre-enrichment and reformulation of tetrathionate broth. Front. Microbiol. 7, 2103 (2016).
25. Ottesen, A. et al. Enrichment dynamics of Listeria monocytogenes and the associated microbiome from naturally contaminated ice cream linked to a listeriosis outbreak. BMC Microbiol. 16, 275 (2016).
26. Abernethy, M. G. et al. Urinary microbiome and cytokine levels in women with interstitial cystitis. Obstet. Gynecol. 129, 500-506 (2017).
27. Chen, T. et al. The human oral microbiome database: A web accessible resource for investigating oral microbe taxonomic and genomic information. Database (Oxford) 2010, baq013 (2010).
28. Zeller, G. et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol. 10, 766 (2014).
29. Viljoen, K. S., Dakshinamurthy, A., Goldberg, P. & Blackburn, J. M. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS One 10, e0119462 (2015).
30. Boleij, A. et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60, 208-215 (2015).
31. Duncan, S. H., Hold, G. L., Harmsen, H. J., Stewart, C. S. & Flint, H. J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 52, 2141-2146 (2002).
32. Sears, C. L., Geis, A. L. & Housseau, F. Bacteroides fragilis subverts mucosal biology: From symbiont to colon carcinogenesis. J. Clin. Invest. 124, 4166-4172 (2014).
33. Flynn, K. J., Baxter, N. T. & Schloss, P. D. Metabolic and community synergy of oral bacteria in colorectal cancer. mSphere 1, e00102-16 (2016).
34. Sears, C. L. Enterotoxigenic Bacteroides fragilis: A rogue among symbiotes. Clin. Microbiol. Rev. 22, 349-369 (2009).
35. Goodwin, A. C. et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc. Natl. Acad. Sci. USA 108, 15354-15359 (2011).
36. Wu, S., Lim, K. C., Huang, J., Saidi, R. F. & Sears, C. L. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc. Natl. Acad. Sci. USA 95, 14979-14984 (1998).
37. Wu, S., Morin, P. J., Maouyo, D. & Sears, C. L. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 124, 392-400 (2003).
38. Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016-1022 (2009).
39. Toprak, N. U. et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin. Microbiol. Infect. 12, 782-786 (2006).
40. Keenan, J. I. et al. Screening for enterotoxigenic Bacteroides fragilis in stool samples. Anaerobe 40, 50-53 (2016).
41. Shah, M. S. et al. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer. Gut https://doi.org/10.1136/gutjnl-2016-313189 (2017).
42. Han, Y. W. Fusobacterium nucleatum: A commensal-turned pathogen. Curr. Opin. Microbiol. 23, 141-147 (2015).
43. Han, Y. W. et al. Identification and characterization of a novel adhesin unique to oral fusobacteria. J. Bacteriol. 187, 5330-5340 (2005).
44. Han, Y. W. et al. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect. Immun. 68, 3140-3146 (2000).
45. Coppenhagen-Glazer, S. et al. Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth. Infect. Immun. 83, 1104-1113 (2015).
46. Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195-206 (2013).
47. Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207-215 (2013).
48. Saito, T. et al. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Nat. Med. 22, 679-684 (2016).
49. Thiele Orberg, E. et al. The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis. Mucosal Immunol. 10, 421-433 (2016).
50. Gur, C. et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42, 344-355 (2015).
51. Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299-306 (2012).
52. Li, Y. Y. et al. Association of fusobacterium nucleatum infection with colorectal cancer in Chinese patients. World J. Gastroenterol. 22, 3227-3233 (2016).
53. Warren, R. L. et al. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 1, 16 (2013).
54. Kolenbrander, P. E., Andersen, R. N. & Moore, L. V. Coaggregation of Fusobacterium nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas noxia, and Selenomonas sputigena with strains from 11 genera of oral bacteria. Infect. Immun. 57, 3194-3203 (1989).
55. Kolenbrander, P. E. & London, J. Adhere today, here tomorrow: Oral bacterial adherence. J. Bacteriol. 175, 3247-3252 (1993).
56. Johnson, C. H. et al. Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab. 21, 891-897 (2015).
57. Flemer, B. et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut https://doi.org/10.1136/gutjnl-2015-309595 (2016).
58. Harris, P. A. et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 42, 377-381 (2009).
59. Fadrosh, D. W. et al. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome 2, 6 (2014).
60. Caporaso, J. G. et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 6, 1621-1624 (2012).
61. Klindworth, A. et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 41, e1 (2013).
62. Bartram, A. K., Lynch, M. D., Stearns, J. C., Moreno-Hagelsieb, G. & Neufeld, J. D. Generation of multimillion-sequence 16S rRNA gene libraries from complex microbial communities by assembling paired-end illumina reads. Appl. Environ. Microbiol. 77, 3846-3852 (2011).
63. Magoc, T. & Salzberg, S. L. FLASH: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957-2963 (2011).
64. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114-2120 (2014).
65. Kuczynski, J. et al. Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Curr. Protoc. Bioinformatics 10, 1-20 (2011).
66. Caporaso, J. G. et al. PyNAST: A flexible tool for aligning sequences to a template alignment. Bioinformatics 26, 266-267 (2010).
67. Bragg, L., Stone, G., Imelfort, M., Hugenholtz, P. & Tyson, G. W. Fast, accurate error-correction of amplicon pyrosequences using Acacia. Nat. Methods 9, 425-426 (2012).
68. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-200 (2011).
69. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359 (2012).
70. McDonald, D. et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6, 610-618 (2012).
71. Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261-5267 (2007).
72. Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814-821 (2013).